Skin appendage disorders · 2025
Hair Loss Treatments: A Google Trends Analysis Worldwide of the Past 5 Years (2018-2023).
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Todorova Lidiya, Kluger Nicolas
Аннотация
INTRODUCTION: We aimed to evaluate the recent trends in public interest regarding various alopecia-related treatments using Google Trends (GT).
METHOD: Data generated through GT for the relative search volumes (RSVs) of the treatments-related terms were analysed: "hair loss treatment"; "minoxidil"; "oral minoxidil"; "finasteride"; "dutasteride"; "hair transplant." Analysis has been performed worldwide from July 29, 2018, to July 16, 2023.
RESULTS: Mean RSVs for "hair loss treatment" have increased since 2021 (23 ± 2.8 in 2018 to 70 ± 7.5 in 2023). Interest in "minoxidil" has been growing since 2018, with "minoxidil oral treatment" gaining attention since 2021. "Finasteride" saw a rise in 2021; "dutasteride" experienced consistent growth. RSVs for "hair transplant" have remained stable. Geographically, public interest in "hair loss treatment" was concentrated in Middle Eastern countries and Japan. Interest in oral treatments was prominent in Latin American and Spanish-speaking countries; Ireland and the UK showed strong focus on hair transplants.
CONCLUSION: GT is not a real epidemiological tool and can be only used by individuals who have access to the Internet. We observed temporal and geographical variations in public interest in hair loss treatments. COVID-19 pandemic, differences in the prevalence of alopecia-related conditions, cultural, social influences impact search trends across countries.
METHOD: Data generated through GT for the relative search volumes (RSVs) of the treatments-related terms were analysed: "hair loss treatment"; "minoxidil"; "oral minoxidil"; "finasteride"; "dutasteride"; "hair transplant." Analysis has been performed worldwide from July 29, 2018, to July 16, 2023.
RESULTS: Mean RSVs for "hair loss treatment" have increased since 2021 (23 ± 2.8 in 2018 to 70 ± 7.5 in 2023). Interest in "minoxidil" has been growing since 2018, with "minoxidil oral treatment" gaining attention since 2021. "Finasteride" saw a rise in 2021; "dutasteride" experienced consistent growth. RSVs for "hair transplant" have remained stable. Geographically, public interest in "hair loss treatment" was concentrated in Middle Eastern countries and Japan. Interest in oral treatments was prominent in Latin American and Spanish-speaking countries; Ireland and the UK showed strong focus on hair transplants.
CONCLUSION: GT is not a real epidemiological tool and can be only used by individuals who have access to the Internet. We observed temporal and geographical variations in public interest in hair loss treatments. COVID-19 pandemic, differences in the prevalence of alopecia-related conditions, cultural, social influences impact search trends across countries.